Ida Surakka

Ida Surakka

Auto-generated profile, based on publicly available information

Ida Surakka

Department of Internal Medicine, University of Michigan, Ann Arbor, MI

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2023 in European Heart Journal
Verified
Journal Article
Open access
PDF file
SCSo Mi Jemma Cho
So Mi Jemma Cho
SKSatoshi Koyama
Satoshi Koyama
MHMichael C Honigberg
Michael C Honigberg
ISIda Surakka
Ida Surakka
SHSara Haidermota
Sara Haidermota
PNPradeep Natarajan
Pradeep Natarajan
Aims: Complications of coronary artery disease (CAD) represent the leading cause of death among adults globally. This study examined the associations and clinical utilities of genetic, sociodemographic, lifestyle, and clinical risk factors on CAD recurrence. Methods and results: Data were from 7024 UK Biobank middle-aged adults with established CAD at enrolment. Cox proportional hazards regressions modelled associations of age at enrolment, age at first CAD diagnosis, sex, cigarette smoking, physical activity, diet, sleep, Townsend Deprivation Index, body mass index, blood pressure, blood lipids, glucose, lipoprotein(a), C reactive protein, estimated glomerular filtration rate (eGFR), statin prescription, and CAD polygenic risk score (PRS) with first post-enrolment CAD recurrence. Over a median [interquartile range] follow-up of 11.6 [7.2–12.7] years, 2003 (28.5%) recurrent CAD events occurred. The hazard ratio (95% confidence interval [CI]) for CAD recurrence was the most pronounced with current smoking (1.35, 1.13–1.61) and per standard deviation increase in age at first CAD (0.74, 0.67–0.82). Additionally, age at enrolment, CAD PRS, C-reactive protein, lipoprotein(a), glucose, low-density lipoprotein cholesterol, deprivation, sleep quality, eGFR, and high-density lipoprotein (HDL) cholesterol also significantly associated with recurrence risk. Based on C indices (95% CI), the strongest predictors were CAD PRS (0.58, 0.57–0.59), HDL cholesterol (0.57, 0.57–0.58), and age at initial CAD event (0.57, 0.56–0.57). In addition to traditional risk factors, a comprehensive model improved the C index from 0.644 (0.632–0.654) to 0.676 (0.667–0.686). Conclusion: Sociodemographic, clinical, and laboratory factors are each associated with CAD recurrence with genetic risk, age at first CAD event, and HDL cholesterol concentration explaining the most.

6 March 2025 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
CRCarolina Roselli
Carolina Roselli
ISIda Surakka
Ida Surakka
MOMorten Olesen
Morten Olesen
GSGardar Sveinbjornsson
Gardar Sveinbjornsson
NMNicholas A Marston
Nicholas A Marston
PEPatrick T Ellinor
Patrick T Ellinor

3 April 2012 in BMC Medical Genomics
Verified
Journal Article
Open access
PDF file
JSJarkko Soronen
Jarkko Soronen
PLPirkka-Pekka Laurila
Pirkka-Pekka Laurila
JNJussi Naukkarinen
Jussi Naukkarinen
ISIda Surakka
Ida Surakka
SRSamuli Ripatti
Samuli Ripatti
HYHannele Yki-Järvinen
Hannele Yki-Järvinen
To get insight into molecular mechanisms underlying insulin resistance, we compared acute in vivo effects of insulin on adipose tissue transcriptional profiles between obese insulin-resistant and lean insulin-sensitive women.

1 June 2012 in Twin Research and Human Genetics
Verified
Journal Article
Open access
PDF file
ISIda Surakka
Ida Surakka
JWJohn B. Whitfield
John B. Whitfield
MPMarkus Perola
Markus Perola
PVPeter M. Visscher
Peter M. Visscher
GMGrant Montgomery
Grant Montgomery
LPLeena Peltonen
Leena Peltonen
Genome-wide association analysis on monozygotic twin-pairs offers a route to discovery of gene–environment interactions through testing for variability loci associated with sensitivity to individual environment/lifestyle. We present a genome-wide scan of loci associated with intra-pair differences in serum lipid and apolipoprotein levels. We report data for 1,720 monozygotic female twin-pairs from GenomEUtwin project with 2.5 million SNPs, imputed or genotyped, and measured serum lipid fractions for both twins. We found one locus associated with intra-pair differences in high-density lipoprotein cholesterol,rs2483058in an intron ofSRGAP2, where twins carrying the C allele are more sensitive to environmental factors (P= 3.98 × 10−8). We followed up the association in further genotyped monozygotic twins (N= 1,261), which showed a moderate association for the variant (P= 0.200, same direction of an effect). In addition, we report a new association on the level of apolipoprotein A-II (P= 4.03 × 10−8).

27 September 2024 in Nature Metabolism
Verified
Journal Article
Open access
PDF file
SDSandeep Das
Sandeep Das
AFAlexandra C. Finney
Alexandra C. Finney
SASumit Kumar Anand
Sumit Kumar Anand
SRSumati Rohilla
Sumati Rohilla
YLYuhao Liu
Yuhao Liu
OROren Rom
Oren Rom
The incidence of metabolic dysfunction-associated steatohepatitis (MASH) is on the rise, and with limited pharmacological therapy available, identification of new metabolic targets is urgently needed. Oxalate is a terminal metabolite produced from glyoxylate by hepatic lactate dehydrogenase (LDHA). The liver-specific alanine-glyoxylate aminotransferase (AGXT) detoxifies glyoxylate, preventing oxalate accumulation. Here we show that AGXT is suppressed and LDHA is activated in livers from patients and mice with MASH, leading to oxalate overproduction. In turn, oxalate promotes steatosis in hepatocytes by inhibiting peroxisome proliferator-activated receptor-α (PPARα) transcription and fatty acid β-oxidation and induces monocyte chemotaxis via C–C motif chemokine ligand 2. In male mice with diet-induced MASH, targeting oxalate overproduction through hepatocyte-specific AGXT overexpression or pharmacological inhibition of LDHA potently lowers steatohepatitis and fibrosis by inducing PPARα-driven fatty acid β-oxidation and suppressing monocyte chemotaxis, nuclear factor-κB and transforming growth factor-β targets. These findings highlight hepatic oxalate overproduction as a target for the treatment of MASH.

19 June 2023 in Cell Genomics
Verified
Journal Article
Open access
ISIda Surakka
Ida Surakka
KWKuan-Han Wu
Kuan-Han Wu
WHWhitney Hornsby
Whitney Hornsby
BWBrooke N. Wolford
Brooke N. Wolford
FSFred Shen
Fred Shen
CWCristen J. Willer
Cristen J. Willer
Stroke is the second leading cause of death and disability worldwide. Stroke prevalence varies by sex and ancestry, possibly due to genetic heterogeneity between subgroups. We performed a genome-wide meta-analysis of 16 biobanks across multiple ancestries to study the genetics of ischemic stroke (60,176 cases, 1,310,725 controls) as part of the Global Biobank Meta-analysis Initiative (GBMI) and further combined the results with previously published MegaStroke. Five novel loci for ischemic stroke (LAMC1, CALCRL, PLSCR1, CDKN1A, and SWAP70) were identified after replication in four additional datasets. One previously reported locus showed significant ancestry heterogeneity (ABO), and one showed significant sex heterogeneity (ALDH2). The ALDH2 association was male specific (males p = 1.67e-24, females p = 0.126) and was additionally observed only in the East Asian ancestry (male) samples. These findings emphasize the need for more diverse datasets with large sample sizes to further understand the genetic predisposition of stroke in different ancestry and sex groups.